Drug information for APLENZIN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET, EXTENDED RELEASE; ORAL
174MG
Prescription
BUPROPION HYDROBROMIDE
Bupropion
VALEANT INTL
22108
2011-07-28 Letter
2011-07-28 Letter
2011-07-27 Label
2011-07-27 Label
2011-07-27 Medication Guide
2011-05-04 Letter
2011-05-04 Letter
2011-05-02 Label
2011-05-02 Medication Guide
2009-12-04 Other
2009-04-07 Review
2009-04-07 Summary Review
2008-05-27 Label
2008-05-27 Medication Guide
2008-04-24 Letter
TABLET, EXTENDED RELEASE; ORAL
348MG
Prescription
(Reference Drug)
BUPROPION HYDROBROMIDE
Bupropion
VALEANT INTL
"
TABLET, EXTENDED RELEASE; ORAL
522MG
Prescription
BUPROPION HYDROBROMIDE
Bupropion
VALEANT INTL
"
Drug Adverse Effects information for APLENZIN
Role code
Indications
Reaction
# Reports
C
CONSTIPATION
BREAST CANCER
1
C
DEPRESSION
BREAST CANCER
1
C
FATIGUE
BREAST CANCER
1
C
GASTROOESOPHAGEAL REFLUX DISEASE
BREAST CANCER
1
C
HYPERCHOLESTEROLAEMIA
BREAST CANCER
1
C
HYPERTENSION
BREAST CANCER
3
C
MAJOR DEPRESSION
ABORTION SPONTANEOUS
1
C
MAJOR DEPRESSION
ANXIETY
1
C
MAJOR DEPRESSION
DISABILITY
1
C
MAJOR DEPRESSION
MAJOR DEPRESSION
1
C
MAJOR DEPRESSION
MATERNAL EXPOSURE DURING PREGNANCY
1
C
MAJOR DEPRESSION
SUICIDAL IDEATION
1
C
MULTIPLE SCLEROSIS
BREAST CANCER
1
C
PRODUCT USED FOR UNKNOWN INDICATION
ABORTION SPONTANEOUS
2
C
PRODUCT USED FOR UNKNOWN INDICATION
ANXIETY
2
C
PRODUCT USED FOR UNKNOWN INDICATION
CONVULSION
6
C
PRODUCT USED FOR UNKNOWN INDICATION
DISABILITY
2
C
PRODUCT USED FOR UNKNOWN INDICATION
MAJOR DEPRESSION
2
C
PRODUCT USED FOR UNKNOWN INDICATION
MATERNAL EXPOSURE DURING PREGNANCY
2
C
PRODUCT USED FOR UNKNOWN INDICATION
SUICIDAL IDEATION
2
Ads by Google